Chapter 1. Enzyme-Linked Immunosorbent Assay (ELISA) market– Scope & Methodology
1.1 Market Segmentation
1.2 Assumptions
1.3 Research Methodology
1.4 Primary Sources
1.5 Secondary Sources
Chapter 2. Enzyme-Linked Immunosorbent Assay (ELISA) market–Executive Summary
2.1 Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2 Key Trends & Insights
2.3 COVID-19 Impact Analysis
2.3.1 Impact during 2023 – 2030
2.3.2 Impact on Supply – Demand
Chapter 3. Enzyme-Linked Immunosorbent Assay (ELISA) market– Competition Scenario
3.1 Market Share Analysis
3.2 Product Benchmarking
3.3 Competitive Strategy & Development Scenario
3.4 Competitive Pricing Analysis
3.5 Supplier - Distributor Analysis
Chapter 4. Enzyme-Linked Immunosorbent Assay (ELISA) market- Entry Scenario
4.1 Case Studies – Start-up/Thriving Companies
4.2 Regulatory Scenario - By Region
4.3 Customer Analysis
4.4 Porter's Five Force Model
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Powers of Customers
4.4.3 Threat of New Entrants
4.4.4 .Rivalry among Existing Players
4.4.5 Threat of Substitutes
Chapter 5. Enzyme-Linked Immunosorbent Assay (ELISA) market- Landscape
5.1 Value Chain Analysis – Key Stakeholders Impact Analysis
5.2 Market Drivers
5.3 Market Restraints/Challenges
5.4 Market Opportunities
Chapter 6. Enzyme-Linked Immunosorbent Assay (ELISA) market- By Product
6.1 Competitive ELISA
6.2 Direct ELISA
6.3 Indirect ELISA
6.4 Sandwich ELISA
Chapter 7. Enzyme-Linked Immunosorbent Assay (ELISA) market- By Application
7.1 Disease Diagnosis
7.2 Vaccine Development
7.3 Other Applications
Chapter 8. Enzyme-Linked Immunosorbent Assay (ELISA) market– By Region
8.1 North America
8.2 Europe
8.3 Asia-Pacific
8.4 Latin America
8.5 The Middle East
8.6 Africa
Chapter 9. Enzyme-Linked Immunosorbent Assay (ELISA) market- Company Profiles – (Overview, Product Portfolio, Financials, Developments)
9.1 Company 1
9.2 Company 2
9.3 Company 3
9.4 Company 4
9.5 Company 5
9.6 Company 6
9.7 Company 7
9.8 Company 8
9.9 Company 9
9.10 Company 10
2850
5250
4500
1800